Clin2
NCT05025865Possibly a fitRecruiting

Study of reducing alcohol use with the HA35 supplement

Healthy Controls

Treatments studied

This early-phase study tests HA35 in people who currently drink less alcohol than typical weekly drinking limits. It aims to see whether the supplement is safe and whether it affects the body in people who are not heavy drinkers.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
24 people
Ages
21 years to 65 years
Study type
Interventional

Who can take part

  • You drink less than 7 drinks per week if you’re a woman, or less than 14 per week if you’re a man
  • You can understand the study and sign written consent
  • You do not have serious long-term (chronic) illnesses such as cancer (except non-melanoma skin cancer)
  • Your diabetes, thyroid, blood pressure, cholesterol, kidneys, and liver must be controlled or normal
  • You have no history of alcohol use disorder and are not currently pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05018481Recruiting· Early Phase 1
Study for moderate alcoholic hepatitis after heavy drinking

This early-phase study is testing a treatment approach for people with alcoholic hepatitis (liver inflammation caused by heavy alcohol use). It may help by improving liver function and outcomes in people who meet specific lab and health criteria.

Cleveland, Ohio
NCT05408247Recruiting· Phase 4
N-acetylcysteine to help people cut back on alcohol

This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.

Sydney, New South Wales
NCT07484893Not yet recruiting· Phase 1
Safety study of hyaluronidase in healthy men

This trial tests a new drug called recombinant human hyaluronidase in healthy men to see if it is safe and how the body handles it. It could help doctors understand if this drug is suitable for future use.

Hefei, Anhui
NCT06710431Not yet recruiting· Phase 2
Testing the safety of oral AFA-281 for alcohol use disorder

This trial tests an experimental medication called AFA-281 to see if it's safe and could help reduce heavy drinking in people with moderate to severe alcohol use disorder. You must drink a high number of drinks per week to qualify.

Los Angeles, California
NCT07783061Not yet recruiting
Alcohol reduction for heart health

This study looks at how reducing alcohol affects blood pressure and heart health. It may help you lower your cardiovascular risk if you drink above recommended limits and have elevated blood pressure.

Arlington, Texas
NCT07542132Not yet recruiting
Hyaluronic Acid Effects on Skin Health Study

This study tests whether a hyaluronic acid product improves skin health and appearance in healthy adults. Hyaluronic acid is a natural substance that helps skin retain moisture and may reduce signs of aging.

Geneva

Hear when a new Healthy Controls trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.